Back to the homepage of inctr.org

INCTR

Rue Engeland 642
B 1180 Brussels, Belgium

P: +32 . 2 . 372-9949
F: +32 . 2 . 372-2402

Branches and Offices

Find us

Jon us on Facebook Join us on Twitter Join us on YouTube

World Health Organization

INCTR is an NGO in
official relations with WHO

GlobalGiving vetted Organization 2015

INCTR UK

The specific aims of the office are to participate in selected INCTR programmatic activities such as the partnership programs between academic institutions in more developed countries and institutions in developing countries and the promotion of the development of an evidence-base of information related to specific cancers that exists within developing countries. 

INCTR UK raises the awareness of policy makers about the importance of cancer as a health problem in developing countries by working with other organizations to include non-communicable diseases in the Millennium Development Goals, thereby ensuring that cancer is given a higher priority in the funding agendas of donors and governments. The Director of INCTR UK serves as INCTR’s Director of Program Development. INCTR UK also works with the INCTR Challenge Fund (Charity no. 1979181), the UK-based charity dedicated to supporting INCTR programs.  For more information about the charity, please click here:  www.challengefund.org.

  • Director:  Mark Lodge

Prama House
267 Banbury Road
Oxford, OX2 7HT
United Kingdom

Tel:  44 1865 339 510
Fax: 44 1865 339 301
Email: mlodge@canet.org

Images

Mr Mark Lodge, Director INCTR UK Office
INCTR UK Office and INCTR Challenge Fund Teams at a Fundraising Event

Help INCTR bring comfort and hope to those who need it most by making a donation, voluntering, or supporting our activities.

Help INCTR


 


INCTR's success depends greatly upon the support of individuals, institutions and corporations worldwide. Members participate in ongoing projects, serve on committees, or simply provide financial and moral support.

Become an INCTR Member


© 2017 INCTR The International Network For Cancer Treatment and Research